Loading resource…

Bruno Garcia and Matthieu Legrand
The commentary reflects on recent findings regarding the administration of vasopressors, particularly angiotensin II and vasopressin, in the context of distributive shock. It highlights the uncertainty surrounding optimal timing for initiation and the implications for patient outcomes. The document reviews existing literature and studies, including the ATHOS-3 trial, to evaluate the effectiveness of early vasopressor administration and its correlation with survival rates.
No account needed